The influenza problem
Share
Dr Bram Palache explains what’s so frustrating about the flu problem.
Influenza is a highly infectious disease that usually strikes during the winter season. Globally, it causes an estimated one billion cases of influenza, resulting in 290,000 to 650,000 deaths per year. A person can get the virus simply by being near an infected person that coughs, sneezes or talks, or by touching something with the virus on it. Although everyone can be affected, some people are more at risk than others, such as the elderly, people with chronic diseases (such as heart disease and diabetes), young children, pregnant women and healthcare professionals. The most effective way to prevent the flu is vaccination.
Produced by the International Federation on Ageing with IFPMA.
More resources on seasonal influenza: https://bit.ly/2KsKQCX
Infographic: https://bit.ly/2x1oWOv
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.
Learn more
Related news and resources
Collaborating for Global Health Progress flyer
Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read more
WHO Intergovernmental Negotiating Body (INB) intersessional briefing on “Access and benefit sharing”
On 22 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 10: WHO Pathogen Access and Benefit Sharing System, with the Pandemic Influenza Preparedness Framework as an example” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreWHO Intergovernmental Negotiating Body (INB) intersessional briefing on the “Sustainable and equitably distributed production”
On 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read more